Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025
$RMTI to release its Q2'25 financial and operational results on Thursday, August 14, 2025.
Share
CONFERENCE CALL AND WEBCAST DETAILS
Date: Thursday, August 14, 2025
Time: 8:00am ET
Live Number: (888) 660-6347 // (International) 1 (929) 201-6594
Conference Call ID: 4944610
Webcast and Replay: www.RockwellMed.com/Results
Speakers:
Mark Strobeck, Ph.D. — President and Chief Executive Officer; and
Jesse Neri — SVP, Chief Financial Officer
Tim Chole — SVP, Chief Commercial Officer
Format: Discussion of second quarter 2025 financial and operational results followed by Q&A.
About Rockwell Medical
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed at freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or in a patient's home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work ® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & Production TM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions TM. For more information, visit www.rockwellmed.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Citizens Financial (CFG) Draws Upgrades as Fee Growth Boosts Outlook
Citizens Financial Group, Inc. (NYSE:CFG) is one of the best bank stocks to buy trading under book value. Citizens Financial Group, Inc. (NYSE:CFG) is attracting renewed optimism from Wall Street after Citi raised its price target to $60 from $57 on July 21, while maintaining a Buy rating. With shares currently trading around $49.20, that implies a potential upside of over 20%, signaling confidence in the bank's near-term prospects. The upward revision follows the company's solid second-quarter performance and encouraging guidance for Q3, particularly in non-interest income areas like fees. Ffooter / In its Q2 earnings report, Citizens reported earnings of $0.65 per share, beating analysts' expectations by a few cents. Although net interest income showed some compression, a common theme across regional banks, strong fee-based revenue and solid expense management helped the bank deliver steady results. Citi noted that Q3 guidance came in stronger than anticipated, especially in fee income, which includes services like wealth management and card-related fees. That improvement could be a sign that Citizens is successfully diversifying its revenue base at a time when interest-rate pressure is hitting lending margins across the sector. As the broader banking sector regains its footing, Citizens' combination of better-than-expected guidance and strong capital positioning makes it a stock to watch. The valuation still leaves room for upside, particularly if fee growth continues into the second half of the year. While we acknowledge the potential of CFG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
7 minutes ago
- Yahoo
IMCD reports EBITA of EUR 275 million in the first half of 2025
Rotterdam, The Netherlands (30 July 2025) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first half 2025 results. HIGHLIGHTS• Gross profit up by 5% to EUR 634 million (+7% on a constant currency basis)• Operating EBITA up by +2% to EUR 275 million (+4% on a constant currency basis)• Free cash flow of EUR 173 million (first half 2024: EUR 221 million)• Cash earnings per share at EUR 2.94 (first half 2024: EUR 3.23)• Expanding our footprint across key markets through six completed acquisitions year to date Marcus Jordan, CEO: "In the first half of 2025 we delivered forex adjusted gross profit growth of 7% and EBITA growth of 4%. We completed six acquisitions across our three regions to further strengthen our capabilities in a range of core market segments. Under challenging and unpredictable macro-economic market conditions, I am assured by the resilience of our asset-light business model and thankful to our teams for their continued growth focus. While these challenging conditions may persist, we are well positioned for the future through our leading speciality focused portfolio, geographic and market diversity combined with advanced digital and supply chain capabilities." Attachment Press release_IMCD first half year 2025 resultsSign in to access your portfolio
Business Insider
20 minutes ago
- Business Insider
DBS Keeps Their Buy Rating on SenseTime Group, Inc. Class B (0020)
DBS analyst Sachin Mittal maintained a Buy rating on SenseTime Group, Inc. Class B today and set a price target of HK$2.10. The company's shares closed yesterday at HK$1.60. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mittal covers the Technology sector, focusing on stocks such as Accenture, Grab, and SenseTime Group, Inc. Class B. According to TipRanks, Mittal has an average return of 24.1% and a 78.32% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for SenseTime Group, Inc. Class B with a HK$1.80 average price target.
